Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Michael Seep

Family Medicine Lake Charles, LA Medical Doctor

NPI 1013993484 CMS profile 318659

2750 Aster St, Lake Charles, LA 70601

Open in the dashboard

General payments

$2,767

206 records reported · program years 2019–2023

Research payments

$391

Paid to them · 2 records reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$9,060,623 paid to institutions, not to them · program years 2019–2023

Through program year 2023, Michael Seep of Lake Charles, LA is reported in the CMS Open Payments database as having received $2,767 across 206 general payments and $391 in research payments paid to them. Separately, studies naming them as principal investigator received $9,060,623 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 85th percentile of Family Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $111 6
2022 General $1,118 74
2021 General $708 54
2021 Research $374 1
2020 General $349 29
2020 Research $16 1
2019 General $481 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Seep
  • Family Medicine median
  • Middle half of Family Medicine
  • National median

In program year 2025, general payments to Michael Seep were reported at $0. Among 56,786 Family Medicine profiles paid that year, the median was $155 and the middle half received between $45 and $549.

Show as a table
Year Michael Seep Family Medicine median Middle half National median
2019 $481 $150 $41–$543 $163
2020 $349 $120 $32–$415 $114
2021 $708 $137 $35–$551 $132
2022 $1,118 $137 $37–$512 $149
2023 $111 $149 $42–$545 $160
2024 $0 $156 $44–$560 $164
2025 $0 $155 $45–$549 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. AbbVie, Inc. $427 35 payments
  2. Pfizer Inc. $316 35 payments
  3. Lilly USA, LLC $243 17 payments
  4. Bayer HealthCare Pharmaceuticals Inc. $192 10 payments
  5. Amgen Inc. $161 20 payments
  6. Novo Nordisk Inc $146 10 payments
  7. AstraZeneca Pharmaceuticals LP $137 11 payments
  8. Astellas Pharma US Inc $131 8 payments
  9. Urovant Sciences Inc $111 1 payment
  10. Janssen Pharmaceuticals, Inc $102 7 payments
  11. Other $801 52 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $2,707 205 payments
  2. Gift $59 1 payment
Products named General payments · program years 2019–2023
  1. ELIQUIS $286 29 payments
  2. UBRELVY $205 15 payments
  3. Kerendia $192 10 payments
  4. GEMTESA $148 3 payments
  5. MOUNJARO $136 7 payments
  6. VRAYLAR $133 12 payments
  7. MYRBETRIQ $131 8 payments
  8. FARXIGA $124 10 payments
  9. RYBELSUS $112 8 payments
  10. XARELTO $102 7 payments
  11. Other $1,993 161 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2023
  1. Eli Lilly and Company $391 2 payments

Records

208 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Family Medicine in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record